Skip to content

Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery

Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03824977
Acronym
PREOTEST
Enrollment
122
Registered
2019-01-31
Start date
2018-11-21
Completion date
2020-02-04
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Neoplasm Malignant, Resectable Lung Non-Small Cell Carcinoma

Keywords

lung resection, low technology, six minutes stepper test, sit to stand test, physiotherapy, lung surgery, post-operative complications

Brief summary

The objective of this study is to evaluate the performances of the Six-Minute Stepper Test (6MST) and Sit To Stand test (STST) to predict post-operative complications after minimally invasive lung cancer resection.

Interventions

The 6MST is done using a stepper (Stepper essential, Decathlon(TM), France), with a walking height of 20 cm, placed in front of a wall or parallel bars, so patients can hold on if necessary. Patients are instructed to make the maximum number of steps possible in 6 minutes, and are given a time check at one minute intervals.

DIAGNOSTIC_TESTSit to stand test (STST)

The STST is done using a chair measuring 47 cm in height. The patient are instructed to sit in the chair and then to do the maximum number of lifts possible from the chair, in 1 minute, with arms folded and without leaning against the chair.

Sponsors

University Hospital, Rouen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>18 * Non-small cell lung cancer stage I to II, justifying major resection by VATS or RATS (segmentectomy, lobectomy, pneumonectomy), with or without histological confirmation

Exclusion criteria

* Partial or total amputation localized to the lower limb; * Weight greater than 100 kg; * Orthopedic, vascular or neurological disorders leading to the incapacity of realize the 6MST; * Patient under tutorship or curatorship; * Pregnant woman. * Surgery canceled

Design outcomes

Primary

MeasureTime frame
occurrence of a post-operative complication grade ≥ 2 on the Clavien-Dindo scale within three months after surgery90 days

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026